Anti-TNF agents linked to shingles risk with rheumatoid arthritis

01/10/2013 | MedPage Today (free registration)

Rheumatoid arthritis patients who took anti-tumor necrosis factor drugs such as etanercept, infliximab and adalimumab had a significantly greater risk of developing shingles than those on disease-modifying antirheumatic drugs, according to a study of more than 15,000 patients in the U.K. The findings appeared in the journal Annals of the Rheumatic Diseases.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID